MCM
MGNX icon

Matarin Capital Management’s MacroGenics MGNX Stock Holding History

Matarin Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-15,221
Closed -$285K – 252
2016
Q1 		$285K Buy
+15,221
New +$290K 0.04% 215
2015
Q3 		– Sell
-6,432
Closed -$244K – 224
2015
Q2 		$244K Buy
+6,432
New +$211K 0.07% 184

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Matarin Capital Management's MGNX Position: Q2 2016 in Review

Matarin Capital Management sold out of MacroGenics (MGNX) in Q2 2016, closing a stake of 15,221 shares — an estimated $285K sold.

Matarin Capital Management first reported a position in MGNX in Q2 2015 and held it in 2 quarters. The position peaked at $285K in Q1 2016. 125 funds tracked by Wall St. Rank hold MGNX as of Q2 2016.

  • Matarin Capital Management reported no remaining MacroGenics position as of Q2 2016 after selling out during the quarter.
  • Matarin Capital Management sold 15,221 MacroGenics shares in Q2 2016, an estimated $285K.
  • Matarin Capital Management first reported a position in MacroGenics in Q2 2015 and held it in 2 quarters.
  • Matarin Capital Management's MacroGenics position peaked at $285K in Q1 2016.
  • 125 funds tracked by Wall St. Rank held MacroGenics as of Q2 2016.

Based on Matarin Capital Management's 13F filing for Q2 2016, filed 10 Aug 2016.